Doctor profile · Federal record
Dr. SHREYA AMIN, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Student in an Organized Health Care Education/Training Program · QUAKERTOWN, PA
- NPI 1407388671
- Accepts Medicare
- MIPS 90.3 / 100 · 2023
- 9 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1021 PARK AVE STE 20
QUAKERTOWN, PA 189510130
(215) 538-4940 - Additional location
-
24 Hospital Ave
Danbury, CT 068106099
(203) 739-8105 - Mailing address
-
207 GREEN HOLLOW DR
ISELIN, NJ 088302921
Credentials & registration
- NPI registered
- March 2017 — 9 yrs on file
- Profile last updated
- April 1, 2022
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Vermont #06.0004959
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407388671. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,306
Distinct HCPCS
10
Medicare allowed
$178,657
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,160 | 26 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 579 | 335 | $132 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 182 | 87 | $35 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 100 | 90 | $183 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 77 | 77 | $168 | |
96372 |
Injection of drug or substance under skin or into muscle | 55 | 29 | $15 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 38 | 32 | $94 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 23 | 23 | $128 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 22 | 13 | $57 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 17 | 13 | $117 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 352. This provider delivers 9.4× the peer median.Open Payments
Industry payments received
All-time total
$860
Transactions
9
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 3 | $355.19 | |
| Dexcom, Inc. | 3 | $154.58 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $135.27 | |
| Medtronic, Inc. | 1 | $125.45 | |
| Abbott Laboratories | 1 | $89.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,324
Patients
453
Total drug cost
$684,503
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 156 | 38 | $212,691 |
| Levothyroxine Sodium | Generic | 145 | 53 | $2,282 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 134 | 42 | $73,219 |
| Jardiance (Empagliflozin) | Brand | 132 | 45 | $160,607 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 106 | 41 | $2,222 |
| Metformin Hcl | Generic | 104 | 38 | $1,207 |
| Novolog Flexpen (Insulin Aspart) | Brand | 88 | 29 | $68,179 |
| Atorvastatin Calcium | Generic | 83 | 30 | $1,460 |
| Glimepiride | Generic | 82 | 28 | $1,328 |
| Ozempic (Semaglutide) | Brand | 78 | 29 | $134,723 |